The adhesins OMP P5 and TfP that facilitate initial attachment have been targeted for vaccine development to prevent biofilm formation, which was successful in evoking a protective immune response to NTHi in the OM model (Novotny and Bakaletz, 2013). This evidence concerns the gene TRIM39 and ocular melanoma.